Evidence map›Paper›PMID 42587543›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Anti-Zic4- and Anti-NMDAR-Positive Patients and Their Correlation with Clinical Course and Image Diagnostic Findings-Case Reports.

Milen Hristozov, Krasimir Shukerski, Antoniya Yaneva, Marianna Murdjeva

Abstract readCase Reports
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Milen HristozovDepartment of Medical Microbiology and Immunology "Prof. Dr. Elissay Yanev", Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0000-0002-4782-8900
Krasimir ShukerskiDepartment of Neurology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Antoniya YanevaDepartment "Medical Informatics, Biostatistics and E-Learning", Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Marianna MurdjevaDepartment of Microbiology and Virology, Medical University of Pleven, 5800 Pleven, Bulgaria.

Funding

Medical University Plovdiv BG-RRP-2.004-0007-C01Medical University Plovdiv DPDP-2/2022
6 · The paper itself

Abstract

BACKGROUND/

objectivesParaneoplastic Neurological Syndromes (PNSs) comprise a rare group of disorders present in various types of malignant neoplasia. In most cases, PNSs precede the clinical symptoms and diagnosis of a tumor by years. It is therefore vital to recognize these neurological disorders, as early diagnosis of the neoplasia offers the opportunity for timely initiation of treatment and may improve patient outcomes. CASE PRESENTATION: Panels of antineuronal antibodies (ANeAs) were used to examine serum and cerebrospinal fluid (CSF) samples from two PNS patients using indirect immunofluorescence assay (IIFA) and immunoblotting (IB). Both patients were anti-Zic4-positive. In addition, one patient was anti-Zic4- and anti-NMDAR-positive. The individuals also exhibited abnormalities on computed tomography (CT) and magnetic resonance imaging (MRI)-focal lesions suggestive of paraneoplastic cerebellar degeneration (PCD) and a tumor. During follow-up neuroimaging examinations, no tumor was found. DISCUSSION: An in-depth study of a case series of PNS patients was carried out. Anti-Zic4 was correlated with PCD, whereas anti-NMDAR was correlated with autoimmune anti-NMDAR encephalitis. These case series may represent a possible non-paraneoplastic cerebellar syndrome associated with autoimmune encephalitis. Moreover, it is necessary for such individuals to undergo long-term follow-up in order to facilitate the early detection of a possible malignant neoplasia.

conclusionsIn the current study, we focus on a case series of two patients with severely impaired neurological status, abnormalities in CT and MRI suggestive of PCD, and positive results for ANeAs-anti-Zic4 and anti-NMDAR. Through this study, we aim to emphasize the need for thorough clinical and laboratory follow-up of patients for eventual tumor development.

Indexed as

antineuronal antibodiesautoimmune encephalitiscase seriesmalignant neoplasiaparaneoplastic cerebellar degenerationparaneoplastic neurological syndromes

Identifiers

PMID42587543
PMCPMC13465069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.